Stay updated on Pembrolizumab in Triple Negative Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Triple Negative Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Triple Negative Breast Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Minor UI/layout adjustments and an updated timestamp, with no changes to the study's core content.
    Difference
    0.1%
    Check dated 2026-03-25T20:52:11.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    Updated the site revision to v3.5.0 and removed the previous v3.4.3 revision.
    Difference
    0.1%
    Check dated 2026-03-18T17:42:21.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3. No visible changes to the study details or page functionality.
    Difference
    0.1%
    Check dated 2026-03-11T10:28:25.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    47 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added. The funding-lapse notice and Revision: v3.4.1 were removed.
    Difference
    0.4%
    Check dated 2026-02-11T01:52:52.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Added a site-wide notice about government funding lapse and updated page to Revision: v3.4.1, replacing v3.4.0; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-03T23:24:13.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The page introduces a glossary toggle and adjusts metadata labels (adding 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0') while removing the prior label 'Last Update Submitted that met QC Criteria' and 'No FEAR Act data'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T00:15:55.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Triple Negative Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Triple Negative Breast Cancer Clinical Trial page.